Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific multimodality therapy, up to half of the patients will develop recurrence. Treatment selection based on a multidisciplinary tumor board represents the cornerstone of head and neck cancer, as it is essential for achieving the best results, not only in terms of outcome, but also in terms of organ-function preservation and quality of life. Evidence-based international and national clinical practice guidelines for head and neck cancer not always provide answers in terms of decision-making that specialists have to deal with in their daily practice. This is the first Expert Consensus on the Multidisciplinary Approach for Head and Neck Squamous Cell C...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
SummaryGiven the complexities of multimodality treatment for patients with head and neck cancer, the...
SummaryGiven the complexities of multimodality treatment for patients with head and neck cancer, the...
Since lymph node metastases are one of the most important prognostic factors, treatment of the neck ...
Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and ne...
In the past two decades, multidisciplinary care has emerged as new way to manage cancer given the ne...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Objectives: A multi-disciplinary team (MDT) is essential in the management of cancer. Head and neck ...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific mu...
SummaryGiven the complexities of multimodality treatment for patients with head and neck cancer, the...
SummaryGiven the complexities of multimodality treatment for patients with head and neck cancer, the...
Since lymph node metastases are one of the most important prognostic factors, treatment of the neck ...
Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and ne...
In the past two decades, multidisciplinary care has emerged as new way to manage cancer given the ne...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Objectives: A multi-disciplinary team (MDT) is essential in the management of cancer. Head and neck ...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...
Background: The Head and Neck Cancer Working Group of Swiss Group for Clinical Cancer Research (SAKK...